Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Research & Development (2016 - 2025)

Cavitation Technologies (CVAT) has disclosed Research & Development for 16 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 75.0% to $4000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82000.0 through Dec 2025, up 67.35% year-over-year, with the annual reading at $95000.0 for FY2025, 55.74% up from the prior year.
  • Research & Development hit $4000.0 in Q4 2025 for Cavitation Technologies, down from $7000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $42000.0 in Q1 2025 to a low of $1000.0 in Q2 2022.
  • Historically, Research & Development has averaged $14071.4 across 5 years, with a median of $9500.0 in 2021.
  • Biggest five-year swings in Research & Development: plummeted 90.0% in 2022 and later surged 433.33% in 2024.
  • Year by year, Research & Development stood at $2000.0 in 2021, then plummeted by 50.0% to $1000.0 in 2022, then soared by 3500.0% to $36000.0 in 2023, then tumbled by 55.56% to $16000.0 in 2024, then plummeted by 75.0% to $4000.0 in 2025.
  • Business Quant data shows Research & Development for CVAT at $4000.0 in Q4 2025, $7000.0 in Q3 2025, and $29000.0 in Q2 2025.